Chronic pain

Research from anesthesiology, pain and critical care journals, sourced from PubMed.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
RCT J Pain Published 12 Nov 2026
Home-based transcranial direct current stimulation and exercise for pain in people with knee osteoarthritis: A mixed-methods pilot randomised controlled trial.
AI-generated abstract summary · verify against the original paper
  • Mixed-methods pilot randomised controlled trial of 24 adults with knee osteoarthritis, combining quantitative feasibility data with semi-structured interviews.
  • Participants were assigned to active or sham home-based tDCS plus an eight-week exercise program, with 10 stimulation sessions over two weeks.
  • Adherence was high: 21/24 (88%) completed at least 75% of tDCS sessions, and no significant adverse events occurred. Mean pain intensity fell in both groups by week 8, from 47.3 to 28.3 (active) and 46.4 to 33.5 (sham).
  • The authors concluded the approach was feasible, acceptable and well tolerated, and that a fully powered trial of 80 participants is warranted to test effects on pain and function.
PubMed indexed 12 Nov 2026 Imported 13 Nov 2026 McNally KR et al. Publisher Chronic pain
RCT BMJ Published 5 Nov 2026
Thoracic epidural versus paravertebral blockade for reducing chronic post-thoracotomy pain (TOPIC-2): open label, parallel group, superiority, multicentre, randomised controlled trial.
AI-generated abstract summary · verify against the original paper
  • Open-label multicentre randomised trial across 15 UK thoracic centres included 737 adults undergoing thoracotomy in the modified intention-to-treat population.
  • The paravertebral group received three single-shot injections before incision plus a catheter, compared with a thoracic epidural catheter loaded with local anaesthetic before incision.
  • Chronic post-thoracotomy pain at six months did not differ significantly, at 22% versus 16% (adjusted RR 1.32, 95% CI 0.93 to 1.86, P=0.12).
  • Paravertebral blockade had less hypotension (12% vs 18%) and pruritus but more urinary retention (12% vs 6%), and day 1 acute pain was higher with paravertebral blockade.
PubMed indexed 5 Nov 2026 Imported 9 Nov 2026 Shelley B et al. Publisher Chronic painRegional
RCT J Pain Published 4 Nov 2026
The Role of Treatment Choice in Open-Label Placebo Analgesia: A Randomized Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized controlled trial of 90 healthy female participants, assigned to an open-label placebo group with choice, an open-label placebo group without choice, or a no-placebo control.
  • Perceived pain was measured with transcutaneous electrical stimulation at baseline and after open-label placebo treatment or a waiting period.
  • Open-label placebo reduced reported pain whether or not participants could choose the placebo type, and the choice group showed no preference for capsules, sprays, or colors.
  • Higher positive superstition was linked to greater pain reduction in the placebo groups, while higher reported pain sensitivity showed the opposite pattern.
PubMed indexed 4 Nov 2026 Imported 9 Nov 2026 Stopper M et al. Publisher Chronic pain
RCT Pain Med Published 1 Nov 2026
Intravenous lidocaine does not provide additional pain reduction beyond placebo in probable nociplastic chronic low back pain: a randomized controlled equivalence trial.
AI-generated abstract summary · verify against the original paper
  • Randomized equivalence trial of 84 adults with chronic non-specific low back pain and probable nociplastic features, conducted at a single rehabilitation department.
  • Participants received weekly IV lidocaine (1 mg/kg bolus, then 4 mg/kg infusion over 4 weeks) or saline placebo, with all receiving amitriptyline and aerobic exercise.
  • At 3 months, the VAS difference was 0.24 (90% CI -0.33 to 0.81), within the prespecified ±1.5 equivalence bounds (TOST P < .001); sleep quality favored lidocaine (mean difference 1.81; 95% CI 0.49-3.14; P = .027).
  • The authors concluded lidocaine gave no additional analgesia over saline alongside multimodal care, and adverse events were more frequent with lidocaine but mild and transient.
PubMed indexed 4 Aug 2026 Imported 9 Nov 2026 Pahari S et al. Publisher Chronic pain
RCT Pain Med Published 1 Nov 2026
A randomized, double-blind, placebo-controlled, parallel group, dose-response study of MR-107A-02 in the treatment of post-surgical dental pain.
AI-generated abstract summary · verify against the original paper
  • Phase 2b randomized, double-blind, placebo-controlled dose-ranging trial in 110 participants after third molar extraction.
  • Oral meloxicam formulation MR-107A-02 given at 1.25, 5, or 15 mg twice daily was compared with placebo.
  • Mean SPID0-24 Emax values were 70.7, 86.7, and 94.8 across the doses, versus 52.0 for placebo; 5 and 15 mg were significant (p < .001).
  • The 15 mg dose gave perceptible relief at 0.6 hours and meaningful relief at 1.5 hours, with the lowest rescue use (29.6%); authors report good tolerability.
PubMed indexed 26 Jul 2026 Imported 9 Nov 2026 Bertoch TM et al. Publisher Chronic painPediatric
RCT Pain Med Published 1 Nov 2026
Sociodemographic factors, but not rurality, explain limited variance in fibromyalgia severity: a secondary analysis of 2 randomized clinical trials.
AI-generated abstract summary · verify against the original paper
  • Secondary analysis of baseline data from 685 participants pooled from two clinical trials, with 44% living in rural areas and 96% female.
  • Rurality and sociodemographic characteristics were examined as baseline factors associated with fibromyalgia severity and other symptom measures.
  • FIQR was associated with age, race, marital status, education, employment, and income but not rurality (t = -0.350, P = 0.726), and sociodemographics explained R2 = 0.09 of FIQR variance.
  • The authors conclude that sociodemographic factors and rurality had limited influence on fibromyalgia severity, pain, fatigue, and pain catastrophizing.
PubMed indexed 11 Jul 2026 Imported 9 Nov 2026 Yarasir Gillette E et al. Publisher Chronic pain
RCT Pain Med Published 1 Nov 2026
Dermabond versus suture fixation for spinal cord stimulator trial lead anchoring: a randomized within-patient controlled trial.
AI-generated abstract summary · verify against the original paper
  • Randomized within-patient trial of 48 adults (96 leads) receiving bilateral thoracic percutaneous spinal cord stimulator trial leads at one academic center.
  • One lead in each patient was randomly anchored with Dermabond and the contralateral lead with suture, and upright radiographic migration was compared.
  • Mean absolute migration was 9.15 mm with Dermabond versus 10.60 mm with suture (paired difference -1.46 mm, 95% CI -6.73 to 3.81; P = .58).
  • Male sex and prior spine surgery predicted more migration, while fixation method did not; the authors call Dermabond clinically comparable to suture.
PubMed indexed 3 Jul 2026 Imported 9 Nov 2026 Hurley RW et al. Publisher Chronic pain
RCT Br J Anaesth Published 28 Oct 2026
Effects of perioperative esketamine infusion on chronic pain after video-assisted thoracoscopic lung resection: a multicentre, randomised, double-blind clinical trial.
AI-generated abstract summary · verify against the original paper
  • Multicentre, randomised, double-blind trial in 873 analysed adults (914 randomised) undergoing video-assisted thoracoscopic lung resection.
  • Perioperative low-dose esketamine (bolus at induction, then intra- and postoperative infusion for 48 h) was compared with normal saline.
  • Chronic pain at 3 months was 14.7% with esketamine versus 21.2% with control (adjusted OR 0.62, 95% CI 0.43-0.90; P=0.013).
  • A post hoc definition using NRS ≥3 during coughing also favoured esketamine (adjusted OR 0.39, 95% CI 0.19-0.84; P=0.015), and the authors report no increase in adverse effects.
PubMed indexed 28 Oct 2026 Imported 9 Nov 2026 Wang QY et al. Publisher Chronic painPerioperative medicine
RCT Pain Med Published 26 Oct 2026
Acetaminophen and chronic post-surgical neuropathic pain: a randomized double blind cross-over study.
AI-generated abstract summary · verify against the original paper
  • Randomized, double-blind, placebo-controlled crossover trial in 30 patients with chronic post-surgical peripheral neuropathic pain at a French university hospital.
  • Participants took oral therapeutic-dose acetaminophen (3 g/day) or placebo for 7 days each, separated by a 7-day washout.
  • Mean pain intensity did not differ from placebo (effect size -0.09, 95% CI -0.45 to 0.26, P = 0.607), and no secondary outcomes differed.
  • The authors found no clinically meaningful short-term add-on analgesic benefit and no adverse events, and advised informing patients about the risks of long-term use.
PubMed indexed 26 Oct 2026 Imported 9 Nov 2026 Gimenez C et al. Publisher Chronic pain
RCT J Pain Published 22 Oct 2026
Effects of cannabidiol (CBD) oral solution in patients undergoing bilateral total knee arthroplasty: A randomized, controlled, parallel, triple blind, pilot study.
AI-generated abstract summary · verify against the original paper
  • Pilot randomized, triple-blind trial of 36 patients undergoing bilateral total knee arthroplasty, split evenly across placebo, 400 mg, and 800 mg oral CBD groups.
  • Four perioperative doses of oral CBD were compared with placebo, all given alongside standardized anesthesia and multimodal analgesia.
  • Dunnett's testing found no significant difference in 72-hour opioid use versus placebo (400 mg: 144 vs 209 MME, p=0.10; 800 mg: 203.2 vs 209 MME, p=0.98).
  • Post hoc testing showed lower opioid use with 400 mg (p=0.04), and the authors frame the findings as a potential signal that needs larger trials.
PubMed indexed 23 Oct 2026 Imported 9 Nov 2026 Sideris A et al. Publisher Chronic pain
RCT Pain Med Published 19 Oct 2026
Pilates combined with Cognitive Functional Therapy in women with chronic nonspecific low back pain: A three-arm randomized controlled trial on physical and psychological outcomes.
AI-generated abstract summary · verify against the original paper
  • Single-blind randomized trial of 120 women aged 20-50 with mild to moderate chronic nonspecific low back pain, comparing three arms over 8 weeks.
  • Compared CFT combined with Pilates against Pilates alone and a control group, with pain intensity as the primary outcome.
  • Both Pilates-based arms outperformed control on pain, disability, and kinesiophobia, but CFT added no difference to Pilates for pain (p = 0.871) or disability (p = 1.000).
  • CFT plus Pilates was superior for kinesiophobia (p = 0.001), trunk flexion endurance (p = 0.003), and lateral-flexion endurance (p = 0.001).
PubMed indexed 19 Oct 2026 Imported 9 Nov 2026 Yalfani A et al. Publisher Chronic pain
RCT Pain Med Published 19 Oct 2026
Perineural or intravenous dexamethasone for adductor canal and iPACK blocks in total knee arthroplasty: A randomised trial.
AI-generated abstract summary · verify against the original paper
  • Randomised, quadruple-blind trial of 90 patients aged 65-100 undergoing primary total knee arthroplasty, comparing dexamethasone adjuncts to adductor canal and iPACK blocks.
  • Perineural dexamethasone (4 mg total, 2 mg per block) with ropivacaine was compared with intravenous dexamethasone 4 mg and with placebo.
  • Median time to first rescue opioid was 4.5 h with placebo, 13.9 h with IV dexamethasone and 18.5 h with perineural dexamethasone (log-rank p < 0.001).
  • Perineural dexamethasone produced lower opioid use than IV at later timepoints, and no motor weakness or nerve injury was reported.
PubMed indexed 19 Oct 2026 Imported 9 Nov 2026 Reysner T et al. Publisher Chronic painPharmacologyRegional
RCT J Pain Published 17 Oct 2026
Acute effects of blood flow restriction on shoulder pain and strength in nonspecific shoulder pain-A randomised crossover trial.
AI-generated abstract summary · verify against the original paper
  • Randomized crossover trial of 48 people with nonspecific shoulder pain, comparing a blood flow restriction session with a sham-BFR session after a 7-day washout.
  • Each session used low-load biceps curls with either BFR or sham-BFR, followed by a standardized shoulder exercise loading session.
  • BFR produced larger immediate MVIC gains (EMD = 0.058, p < 0.05) and larger gains after loading (EMD = 0.042, p < 0.05) than sham; PPT rose only after BFR (infraspinatus EMD = 1.32; middle deltoid EMD = 1.27).
  • The authors conclude that a single BFR session gave immediate, clinically meaningful pain reduction and strength gains, though both conditions reduced pain.
PubMed indexed 16 Oct 2026 Imported 9 Nov 2026 Pavlou K et al. Publisher Chronic pain
RCT Pain Published 16 Oct 2026
Mechanisms of behavioral activation, cognitive therapy, and mindfulness meditation for chronic pain: a test of specific vs shared mechanism models in a randomized clinical trial.
AI-generated abstract summary · verify against the original paper
  • Randomized trial of 302 adults with chronic low back pain across three arms (behavioral activation, cognitive therapy, mindfulness meditation), using twice-daily ecological momentary assessment and daily activity monitoring.
  • The study tested whether changes in pain catastrophizing, mindful nonjudgment, and activity level accounted for improvement in pain interference, during and after treatment.
  • All three treatments improved pain interference, catastrophizing, and nonjudgment with no between-treatment differences, but activity level did not change.
  • Structural equation models found mostly nonsignificant cross-lagged effects, though outcome and mechanism changes were correlated, and the authors favored a shared mechanisms model.
PubMed indexed 2 Nov 2026 Imported 9 Nov 2026 Day MA et al. Publisher Chronic pain
RCT Anesth Analg Published 12 Oct 2026
Cranial Electrotherapy Stimulation for Fibromyalgia in Veterans: A Randomized Sham-Controlled Feasibility Study of Resting-State Functional Connectivity Magnetic Resonance Imaging to Evaluate Pain and Treatment Response.
AI-generated abstract summary · verify against the original paper
  • Randomized, double-blind, sham-controlled feasibility trial at one US government hospital enrolled 48 veterans with fibromyalgia, with 47 analyzed.
  • Participants self-administered in-home cranial electrotherapy stimulation or sham for 60 minutes daily over 12 weeks, with resting-state fMRI at baseline, 6, and 12 weeks.
  • Both groups improved versus baseline at 12 weeks, including DVPRS pain (-1.88 ± 2.2), with significant between-group differences only for sleep interference (P = .04).
  • Authors report similar pain and functional improvement in both arms, and imaging showed differential cerebellar-visual connectivity changes, supporting feasibility of larger trials.
PubMed indexed 13 Oct 2026 Imported 9 Nov 2026 Woodbury A et al. Publisher Chronic pain
RCT J Pain Published 26 Sep 2026
Modulating pain via virtual-reality-based interoceptive modeling: A randomized crossover experiment in an all-female sample.
AI-generated abstract summary · verify against the original paper
  • Randomized crossover study of 60 healthy women (mean age 25.13) exposed to capsaicin-induced acute thermal pain across two virtual reality sessions.
  • The experimental arm received VR-based Interoceptive Modeling, compared with a control arm receiving VR pain visualization without the interoceptive modeling component, separated by a one-week washout.
  • Pain intensity was lower in the experimental condition (Mdiff=5.30, 95% CI 0.34-10.27, p=.037), and immediate post-intervention RMSSD was higher (Mdiff=6.97, 95% CI 3.12-10.83, p<.001).
  • The authors describe Interoceptive Modeling as a promising non-pharmacological approach but state that further research is needed.
PubMed indexed 25 Sep 2026 Imported 9 Nov 2026 Felnhofer A et al. Publisher Chronic pain
RCT Pain Published 15 Sep 2026
From research to practice: adapting graded sensorimotor retraining for people with chronic low back pain.
AI-generated abstract summary · verify against the original paper
  • This two-stage adaptation study used established frameworks, combining an adaptation working group, evidence review, interest-holder engagement and expert consultation to adapt the RESOLVE program for chronic low back pain.
  • Stage 2 used a structured consensus meeting to propose and finalise adaptations to the intervention's content, delivery, resources and clinician training.
  • The consensus process finalised 8 adaptations that refine and streamline existing RESOLVE components rather than removing or adding whole elements.
  • The authors present the approach as practical guidance for adapting RESOLVE and other complex treatments for clinical implementation, though the adapted program's effects were not reported.
PubMed indexed 17 Sep 2026 Imported 9 Nov 2026 Venter M et al. Publisher Chronic pain
RCT Pain Published 9 Sep 2026
Pharmacological modulation of peripheral nerve excitability: a novel way to investigate sodium channel subtypes in humans.
AI-generated abstract summary · verify against the original paper
  • Randomized, placebo-controlled, double-blinded crossover-style study in 20 healthy participants testing topical drugs on peripheral sensory nerve excitability.
  • Compared topical 5% lidocaine, 10% phenytoin and 2% mepyramine against placebo, measuring perception threshold changes with a new sodium channel nociceptor testing protocol.
  • Perception threshold increases differed between drugs (P < 0.01) and versus placebo (P < 0.01), except phenytoin (P = 0.22), which did not differ significantly.
  • Authors report a computational model suggesting lidocaine and mepyramine alter Nav1.7, 1.8 and 1.9 currents differently, supporting the protocol for probing subtype-specific pharmacology.
PubMed indexed 17 Sep 2026 Imported 9 Nov 2026 Andresen T et al. Publisher Chronic painRegional
RCT J Pain Published 5 Sep 2026
U.S. Veterans with low back pain benefit from transcranial direct current stimulation: Results from a cognitive behavioral therapy randomized controlled trial.
AI-generated abstract summary · verify against the original paper
  • Double-blind randomized controlled trial of 115 Veterans with chronic low back pain and prescription opioid misuse (NCT02483468).
  • Participants received either real or sham transcranial direct current stimulation during 11 sessions of Cognitive Behavioral Therapy for Chronic Pain.
  • Real stimulation showed significant time-by-group interactions for pain and functional impairment, with a steeper decline than sham.
  • Opioid misuse decreased over time in both groups with no added benefit from stimulation, and the authors describe it as a promising adjunct.
PubMed indexed 5 Sep 2026 Imported 9 Nov 2026 Douglass MA et al. Publisher Chronic pain
RCT Pain Physician Published Sep 2026 (day not reported)
Comparative Effectiveness of Nucleoplasty and Intradiscal Ozone Therapy for Lumbar Disc Herniation: A Double-Blind, Randomized, Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized, double-blind trial of 90 patients with lumbar disc herniation at a tertiary care center.
  • Compared intradiscal ozone therapy with percutaneous lumbar nucleoplasty, assessing pain (VAS), disability (ODI), and quality of life (SF-36) at baseline, 1 month, and 12 months.
  • Both groups improved significantly on VAS and ODI at 1 and 12 months (P < 0.001), with nucleoplasty showing lower scores than ozone at both time points.
  • The authors conclude both procedures are effective and that nucleoplasty has superior long-term outcomes, though the abstract reports no effect sizes or confidence intervals.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Kilic M et al. Chronic pain
RCT Pain Physician Published Sep 2026 (day not reported)
Ultrasound- and Fluoroscopy-Guided Curved Needle Lumbar Sympathetic Radiofrequency Ablation for Diabetic Peripheral Neuropathy Pain: A Randomized Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized trial of 60 patients with diabetic peripheral neuropathic pain at one hospital in China, split into curved-needle (n=30) and straight-needle (n=30) lumbar sympathetic radiofrequency ablation groups.
  • The comparison was curved-needle versus straight-needle technique for lumbar sympathetic ganglion radiofrequency ablation, both guided by ultrasound and fluoroscopy and combined with anhydrous ethanol.
  • The curved needle group had shorter procedure time (10.6 ± 3.1 vs 15.2 ± 2.3 min, P < 0.001), fewer needle redirections (0.5 vs 4.5) and fewer bone contacts (1.0 vs 4.0), all P < 0.001.
  • Success rate (96.7% vs 90.0%, P = 0.611), VAS pain scores and complications (3.33% vs 13.33%, P = 0.357) did not differ significantly, and the authors report higher satisfaction with the curved needle.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Wang M et al. Chronic pain
RCT Pain Physician Published Sep 2026 (day not reported)
Prolozone M Therapy's Analgesic Efficacy for Managing Moderate-to-Severe Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized, double-blind, placebo-controlled trial of 180 patients with moderate-to-severe knee osteoarthritis (Kellgren-Lawrence 3 or 4) at a single Indian tertiary pain clinic.
  • Patients received three intraarticular injections, every 3 weeks, of hypertonic dextrose, ozone, and magnesium (Prolozone M), compared with corticosteroid or saline.
  • At 24 weeks, WOMAC pain improved more than with corticosteroid (mean change -2.3, 98.3% CI -3.8 to -0.8, P<0.001, d 0.88); saline comparison is not reported in the abstract.
  • The authors conclude the therapy is safe and provides clinically relevant analgesia, with early signs of chondroprotection on radiographs.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Niraj G et al. Chronic pain
RCT Pain Physician Published Sep 2026 (day not reported)
The Effect of Unilateral Subcostal Transversus Abdominis Plane Block Applied as Single or Multiple Injections on Pain in Laparoscopic Cholecystectomy.
AI-generated abstract summary · verify against the original paper
  • Prospective, randomized, single-center trial of 90 adults (89 completed) undergoing elective laparoscopic cholecystectomy, allocated to single-injection, multi-injection, or no-block groups.
  • Ultrasound-guided unilateral subcostal TAP block was given as a single injection or as multiple injections, compared with no block.
  • The multi-injection group had the lowest 24-hour tramadol use and lower VAS scores at 1, 6, and 24 hours (P<0.05), with PONV-free rates of 92% vs 64% vs 52% (P=0.007).
  • The authors conclude both block types gave effective analgesia, with the multi-injection technique showing superior pain control and higher patient satisfaction (P<0.001).
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Nihan OMG et al. Chronic painRegional
RCT Pain Physician Published Sep 2026 (day not reported)
Comparison of the Effects of Normal Saline, Hypertonic Saline, and Hyaluronidase on Patients with Postoperative Relapse of Carpal Tunnel Syndrome: A Randomized Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • A single-center randomized controlled trial in Iran enrolled 90 patients with carpal tunnel relapse after surgery, split into three groups of 30 and followed for 12 months.
  • Patients received ultrasound-guided hydrodissection with hyaluronidase 300 IU, hypertonic saline 5%, or normal saline, each combined with methylprednisolone and bupivacaine.
  • All groups improved, but the hyaluronidase group had significantly greater reductions in VAS and Symptom Severity Scale scores at every follow-up (P < 0.01).
  • Hyaluronidase also required fewer reinjections and reported the highest satisfaction, while hypertonic and normal saline did not differ significantly.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Shahrezaee M et al. Chronic painPediatric
RCT JAMA Intern Med Published 1 Sep 2026
Mindfulness-Based Group Medical Visits for Persons With Chronic Low Back Pain: A Randomized Clinical Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized trial of 451 adults with chronic low back pain recruited from primary care clinics in Massachusetts, Pennsylvania, and North Carolina, randomized 1:1.
  • Participants received an 8-week telehealth-delivered mindfulness group medical visit program or usual care.
  • At 6 months, PEG scores improved more with the intervention (between-group difference -0.62, 95% CI -1.02 to -0.23; P = .002), but the prespecified 1-point MCID was not met at any time point.
  • Significant between-group differences were also reported at 8 weeks and 12 months, and the authors describe the program as scalable and nonpharmacologic.
PubMed indexed 29 Jun 2026 Imported 9 Nov 2026 Morone NE et al. Publisher Chronic pain
RCT Pain Med Published 1 Sep 2026
The effects of neuromodulation through brainwave entrainment on pain in women with fibromyalgia: a randomized controlled clinical trial with follow-up.
AI-generated abstract summary · verify against the original paper
  • Randomized controlled trial of 84 women with fibromyalgia, assigned to music therapy (n=42) or brainwave entrainment via a BrainTap headset (n=42), with 6-month follow-up.
  • Brainwave entrainment was given for 20 minutes daily, 5 days a week, for 8 weeks, and was compared against music therapy delivered on the same schedule.
  • The brainwave entrainment group reduced pain on the VAS and the McGill pain questionnaire PRI total score (P = .0001), with no confidence intervals reported.
  • The authors conclude that brainwave entrainment may relieve pain and improve quality of life, possibly through lower oxidative stress and BDNF levels, though music therapy also improved some measures.
PubMed indexed 12 May 2026 Imported 9 Nov 2026 de Souza G et al. Publisher Chronic pain
RCT Pain Med Published 1 Sep 2026
The safety and effectiveness of lumbar transforaminal injection of sterile amniotic fluid filtrate compared to steroid for lumbosacral radicular pain due to spinal stenosis: a phase I/II double-blinded randomized trial.
AI-generated abstract summary · verify against the original paper
  • Double-blinded randomized phase I/II trial of 58 participants with radicular pain from lumbosacral spinal stenosis.
  • Transforaminal injection of sterile amniotic fluid filtrate was compared with dexamethasone, with safety and pain and function outcomes followed to 6 months.
  • At 3 months, more dexamethasone patients had at least 50% pain reduction: back 45.8% vs 15.0% (P=.050) and leg 60.0% vs 25.0% (P=.034).
  • Adverse event rates were comparable between groups with no serious intervention-related events, and the trial was stopped early after dexamethasone showed greater benefit.
PubMed indexed 31 Mar 2026 Imported 9 Nov 2026 McCormick ZL et al. Publisher Chronic painPharmacology
RCT Interv Pain Med Published 25 Aug 2026
Five-year outcomes from a multi-center prospective randomized controlled trial of minimally invasive interspinous fixation versus open direct decompression for lumbar spinal stenosis.
AI-generated abstract summary · verify against the original paper
  • Multicenter randomized controlled trial of 48 patients with lumbar spinal stenosis, reporting outcomes out to five years.
  • Interspinous fixation device (IFD) with indirect decompression was compared with standard open direct decompression; five-year data were reported for 18 IFD and 25 decompression patients.
  • At five years, the IFD group improved significantly on ODI (-53%), VAS-leg (-66%), VAS-back (-60%) and ZCQ (-29%); decompression improved on three of four measures, not VAS-leg (-64%).
  • The authors report comparable overall clinical success and favorable IFD perioperative metrics, including 80% less blood loss, but describe the comparisons as exploratory.
PubMed indexed 5 Sep 2026 Imported 9 Nov 2026 Baranidharan G et al. Publisher Chronic pain
RCT Anesth Analg Published 24 Aug 2026
Prolonged Continuous Theta Burst Stimulation With Transcranial Magnetic Stimulation Analgesic Effects and Corticospinal Excitability in Chronic Neuropathic Pain: A Randomized Clinical Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized, sham-controlled, double-blind trial of 94 adults with chronic neuropathic pain, with responders and nonresponders followed in later parts.
  • Five days of prolonged continuous theta burst stimulation (pcTBS), 10-Hz rTMS, or sham over left M1; nonresponders then received left DLPFC stimulation.
  • Both active M1 groups reduced pain from baseline (10-Hz 37.9 ± 17.5 vs 48.5 ± 16.0, P < .001; pcTBS 35.1 ± 15.3 vs 47.1 ± 15.1, P < .001), with no difference between them (P = .16).
  • pcTBS produced faster corticospinal excitability changes than sham (MEP 188.5 ± 39.8 vs 102.2 ± 6.9, P = .044). The authors conclude pcTBS is comparable to 10-Hz rTMS with substantially less treatment time.
PubMed indexed 26 Aug 2026 Imported 9 Nov 2026 Liu Y et al. Publisher Chronic pain
RCT J Pain Published 23 Aug 2026
Behavioral pain interventions improve sleep via reduced pain interference and catastrophizing: Secondary longitudinal mediation analysis.
AI-generated abstract summary · verify against the original paper
  • Secondary longitudinal mediation analysis of a 3-arm randomized trial (N = 223) in chronic low back pain, pooling 8-session CBT and 1-session Empowered Relief versus 1-session health education.
  • Latent growth curve models tested whether changes in pain intensity, interference, catastrophizing, and self-efficacy over 3 months mediated improvements in sleep.
  • Reductions in pain interference and catastrophizing were linked to indirect pathways to better sleep, while pain intensity was not, and self-efficacy showed a partial pathway.
  • The authors suggest that targeting pain interference and pain-related cognitions may produce benefits across both sleep and pain; the abstract reports no effect sizes or confidence intervals.
PubMed indexed 23 Aug 2026 Imported 9 Nov 2026 Kim S et al. Publisher Chronic pain
RCT Pain Med Published 20 Aug 2026
Comparison of the Effects of Phenol Neurolysis and Conventional Radiofrequency Thermocoagulation Applied to the Genicular Nerves on Pain in Patients Who Underwent Knee Arthroplasty: A Prospective, Controlled Study.
AI-generated abstract summary · verify against the original paper
  • Prospective quasi-randomized controlled trial of 109 patients with persistent pain after knee arthroplasty, assigned by procedure group to genicular nerve treatment.
  • Compared conventional radiofrequency thermocoagulation (RFT) with chemical neurolysis using phenol of the genicular nerves.
  • Phenol had lower NRS at 1 month (3.67 vs 4.09, p=0.015) and 6 months (5.02 vs 6.52, p<0.001); 6-month ≥50% improvement was 43.6% vs 18.5% (p=0.005).
  • Authors conclude both treatments are effective for persistent post-arthroplasty pain, complications were similar (5.5% vs 3.7%), and phenol's short-term benefit needs long-term confirmation.
PubMed indexed 20 Aug 2026 Imported 9 Nov 2026 Ertilav D et al. Publisher Chronic pain
RCT Pain Published 17 Aug 2026
Verbally induced placebo effects on heat pain tolerance in preschool-aged children.
AI-generated abstract summary · verify against the original paper
  • This experimental study tested 117 children aged 3 to 6 years using a developmentally adapted heat pain tolerance task.
  • A 'magical' analgesic cream placebo was compared with a control cream and with a natural history condition.
  • Placebo effects on heat pain tolerance were significant versus both controls, and larger versus the control cream than versus natural history.
  • No placebo effect appeared on self-reported pain, and stronger effects were seen in younger children, those with higher inhibitory control, and children of more optimistic mothers.
PubMed indexed 18 Aug 2026 Imported 9 Nov 2026 Kamper-Fuhrmann E et al. Publisher Chronic painPediatric
RCT J Pain Published 29 Jul 2026
Social determinants of health as predictors of latent symptom clusters in patients undergoing maintenance hemodialysis: A secondary analysis of the HOPE consortium randomized trial.
AI-generated abstract summary · verify against the original paper
  • Secondary analysis of baseline data from 643 maintenance hemodialysis patients with chronic pain enrolled in the HOPE Consortium trial.
  • Latent profile analysis identified five symptom clusters, and social determinants of health were examined as predictors of cluster membership.
  • Higher everyday discrimination was linked to higher odds of moderate-anxiety and high-all-symptoms clusters, relative to the average-symptom cluster; no effect sizes or CIs are reported in the abstract.
  • Greater residential segregation was associated with higher odds of the low-anxiety cluster, and greater income inequality with the moderate-anxiety cluster; the authors call for multi-level interventions.
PubMed indexed 29 Jul 2026 Imported 9 Nov 2026 Steel JL et al. Publisher Chronic pain
RCT J Pain Published 22 Jul 2026
The impact of social support cues on pain-related fear and avoidance learning.
AI-generated abstract summary · verify against the original paper
  • Randomized experiment in 81 pain-free participants assigned to social support, social safety, or social threat picture cues during an operant robotic-arm pain-avoidance task.
  • Social support cues (a picture of a supportive figure) were compared with sex-matched smiling-stranger safety cues and angry-stranger threat cues.
  • Avoidance learning was successfully acquired, but the three groups did not differ on any outcome, including self-reported pain-expectancy, pain-related fear, or fear-potentiated startle.
  • The authors conclude that social support cues do not modulate operant pain-avoidance, self-reported fear, or pain-expectancy, unlike arousal-based fear measures.
PubMed indexed 22 Jul 2026 Imported 9 Nov 2026 Vasilache A et al. Publisher Chronic pain
Older